Wednesday, 18 Oct 2017

You are here

Acute Coronary Syndrome Increased in Early Rheumatoid Arthritis

It does not come as a surprise to anyone anymore that Acute Coronary Syndrome (ACS) is one of the major causes of morbidity and preterm mortality in RA. What we don’t know is what measures need to be taken to modify the risk and how effective such measures are.

This nationwide population-based cohort study addresses the issue of efficacy of treatment options and treatment algorithms in reduction of ACS in RA patients.

Newly diagnosed RA patients (Diagnosis within 12 month of symptom onset) from the Swedish Rheumatology Quality (SRQ) were matched randomly with individuals from the Swedish Population Register. Patients with preexisting ACS were excluded.

After 15,744 patients with RA and 70,899 comparator subjects were analyzed. In both groups incidence of ACS was higher Among men and increased with age.

RA was found to be associated with approximately 40% higher risk of ACS, HR 1.41 (95% CI 1.29 to 1.54). Amongst RA patients, ACS risk was higher with seropositive RA and in patients with DAS28 above 3.2 at diagnosis. The decline in incidence over time was equally pronounced in the RA cohort as in the general population.

Given that incidence of ACS was higher in the first year after diagnosis, the authors speculated that use of prescribed or over-the-counter COX inhibitors or oral glucocorticoids during the first months of RA disease and high disease activity may contribute to the increased morbidity during the first year.

Results of the study suggest that patients with RA may have benefited from the CVD prevention and risk factors identification and intervention.

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Increased Deaths in RA, Despite Decreasing Mortality Rates

Data from the Swedish Rheumatology Quality (SRQ) Register studied death rates in patients with rheumatoid arthritis (RA) between 1997 and 2014.  Holmqvist and colleagues studied 17,512 RA and 78,847 matched controls from the general population, until their death.

For both the RA patients and general population, they noted steady decrease in mortality rates over time.

Mortality with Interstitial Lung Disease in Rheumatoid Arthritis

Annals of Rheumatic Disease has published a Danish population based study demonstrating the high mortality rates seen with interstitial lung disease (ILD).

Between the years 2004 and 2016, researchers identified 679 RA patients with RA-ILD and matched these (age, gender) against 11 722 RA patients without ILD.

Sarcoid and Rheumatoid Arthritis Risk Increased by Silica Exposure

A Swedish study has shown that occupational silica exposure increases the incidence rates of sarcoidosis and rheumatoid arthritis (RA) in those exposed workers in Swedish iron foundries.

Researchers studied personnel records from 10 iron foundries to identify workers who may be at risk.  They examined 2187 silica-exposed male workers exposed for at least 1 year for a total of 23,807 person-years at risk.

Rheumatoid Arthritis Augments Cardiovascular Risk

A large multi-center study of cardiovascular (CV) risk factors in rheumatoid arthritis (RA) has shown, after nearly 6 years follow-up, more CV events in males than females (21% vs. 11%, respectively) and that RA itself accounts for 30% of the attributable CV risk.

Do Rheumatologists Use ACR/EULAR Guidance on Rheumatoid Arthritis? “Live Vote” Results

The June 2017 RheumNow “Live Vote” surveyed US and non-US rheumatologists and patients about how they diagnose and treat rheumatoid arthritis (RA) and whether they rely on newer diagnostic criteria and management guidelines propagated by the American College of Rheumatology (ACR).